Custodiol-HTK (Histidine-tryptophan-ketoglutarate) Solution as a Cardioplegic Agent

Clinical trial NCT01681095 · COMPLETED

Trial details

NCT number: NCT01681095
Sponsor: Marc Sakwa, MD
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronary Artery Disease Myocardial Ischemia Coronary Disease Heart Diseases Valvular Heart Disease

Start date: 2012-08-01
Primary completion: 2014-08-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.